
CAS 956483-02-6
:Formula:C27H35N3O6
InChI:InChI=1S/C27H35N3O6/c1-4-5-6-7-17-8-10-18(11-9-17)21-12-19-14-30(27(33)29-25(19)36-21)23-13-20(31)22(35-23)15-34-26(32)24(28)16(2)3/h8-12,14,16,20,22-24,31H,4-7,13,15,28H2,1-3H3/t20-,22+,23+,24-/m0/s1
InChI key:FJRRWJMFUNGZBJ-RBVMOCNTSA-N
SMILES:CCCCCC1=CC=C(C=C1)C2=CC3=CN(C(=O)N=C3O2)[C@H]4C[C@@H]([C@H](O4)COC(=O)[C@H](C(C)C)N)O
Filter by
Purity percentage
0
100
|
0
|
50
|
90
|
95
|
100
Found 2 products.
- Lower prices
- Higher prices
- Lower purities
- Higher purities
- Faster estimated delivery
FV 100-d7 (Major)
CAS:Controlled ProductApplications FV 100-d7 is labelled FV 100 (F870000), an orally available nucleoside analogue prodrug of CF-1743 (C291710) which is used for the treatment of herpes zoster, or shingles, which is an infection caused by the reactivation of varicella zoster virus or VZV.
References McGuigan, C., et al.: J. Med. Chem., 43, 4993 (2000); McGuigan, C., et al.: J. Antimicro. Chemother., 60, 1316 (2007); Andrei, G., et al.: Antimicro. Agents Chemother., 49, 1081 (2005)Formula:C27D7H28N3O6Color and Shape:NeatMolecular weight:504.626Valnivudine
CAS:Valnivudine, oral BCNA antiviral, targets herpes zoster; transforms into CF-1743 in body.Formula:C27H35N3O6Purity:98%Color and Shape:SolidMolecular weight:497.58

